Corcept Therapeutics said on Monday its experimental combination ovarian cancer drug improved survival in patients with a ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Corcept Therapeutics said on Monday its experimental ovarian cancer drug in combination with chemotherapy met the main goal of a late-stage trial.

Ovarian cancer—known as a silent killer due to its inability to showcase most of its symptoms—kills many women every year ...

A grieving daughter is campaigning for a new law requiring mandatory second opinions on benign cancer diagnoses within the ...

The Company Successfully Reaches the Second Milestone of ARPA-H $10 Million Award AUSTIN, TX / ACCESS Newswire / March 31, 2025 / Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical b ...

A woman who discovered she had breast cancer after a chance reading of a newspaper article is warning others with Jewish heritage of the increased risk. | ITV News Central ...

A grieving woman from Ipswich hopes that a new law will create changes in the NHS, after her mum died from a misdiagnosed cancer.

Chloe Hickman wants to make it mandatory for benign test results to receive a second opinion from a specialist.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Teacher Retirement System of Texas increased its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 26.4% ...

Pre-Clinical Study in Collaboration with Netherlands Cancer Instituteis in addition to LIXTE’s Ongoing Clinical Trials for ...